Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Nir London
10.11.2023
Structural Biology, Biochemistry, Viruses & Microorganisms, Molecular and Cell Biology, Disease, Drugs & Diagnostics
An open-access format for drug discovery is helping design medications against potential viral threats
28.11.2021
Structural Biology, Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A particularly “sticky” molecule could lead to the development of an effective treatment for cancer
29.09.2021
Structural Biology, Disease, Drugs & Diagnostics, Benefiting Humanity, Diagnostic Techniques and Drugs
COVID Moonshot – the world's largest open-science drug discovery effort – aims to identify pre-clinical candidate molecules, with first clinical...
06.06.2021
Dr. Nir London is the recipient of the 2021 EFMC Prize for a Young Medicinal Chemist or Chemical Biologist in Academia
11.05.2021
Dr. Nir London is the recipient of the EFMC Prize for a Young Medicinal Chemist or Chemical Biologist in Academia
04.05.2020
Bioinformatics and Computational Biology, Immunology, Disease, Drugs & Diagnostics, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
An international initiative aims to identify compounds that target a key enzyme in the virus's life cycle
28.10.2019
Researchers screened thousands of compounds with a unique computer algorithm, finding one that may allow farmers to significantly cut insecticide...
31.01.2019
Bioinformatics and Computational Biology, Biochemistry, Personalized Medicine, Systems Biology, Immunology, Disease, Drugs & Diagnostics, Biotechnology, Diagnostic Techniques and Drugs
A unique method for identifying bioactive chemical compounds produces a potential new drug molecule
22.01.2019
A new "winter school" has its first session at the Weizmann Institute of Science
10.04.2018
Dr. Nir London is the recipient of the Breast Cancer Research Foundation-AACR Career Development Award
